The company is a biotechnology company specializing in the detailed structural analysis and design of complex sugars (polysaccharides) for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. The company formed a collaboration with sandoz to jointly develop, manufacture and commercialize m-enoxaparin. The company wholly operates in United States
